UPC APP 19959/2024

—·EP3646825: A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Sonstige prozessuale
Parteien: Kläger
Edwards Lifesciences Corporation
Vertreter: Boris Kreye (Bird & Bird LLP); Siddharth Kusumakar (Powell Gilbert (Europe) LLP); Bernhard Thum (Thum & Partner)
Beklagte
Meril Italy S.r.l.
Vertreter: Emmanuel Larere (Cabinet Gide Loyrette Nouel AARPI); Raphaëlle Dequiré-Portier (Cabinet Gide Loyrette Nouel AARPI)
Division: Paris CD
Richter: Paolo Catallozzi · Presiding Judge and Judge-Rapporteur
Tatyana Zhilova · Legally Qualified Judge
Stefan Wilhelm · Technically Qualified Judge
Technology: Pharmaceutical & Medical
Sprache: —
Erste Entscheidung: 30. Apr. 2024

Entscheidungen

2024-04-30
Generic application
The Paris Central Division exercised its discretion to admit Edwards Lifesciences' subsequent request to amend patent EP 3 646 825 after the written procedure had closed, provided that Meril Italy was granted additional time to submit a defence to the new amendment, holding that such admission does not prejudice the opposing party's right of defence.
Rechtsfragen:subsequent request to amend patent R.30(2) RoPcourt discretion after closure of written procedureright of defence

Dokumente

2024-04-30%20CD%20Paris%20UPC_CFI_255-2023%20-%20ORD_24620-2024%20App_19959-2024%20and%2023242-2024%20-%20anonymized.pdf2024-04-30EN